---
figid: PMC7609840__fimmu-11-591176-g001
figlink: pmc/articles/PMC7609840/figure/F1/
number: F1
caption: Schematic representation of relevant JAK-STAT signaling pathways in the pathogenesis
  of Spondyloarthritis. Binding of the different Interleukins (IL) to their specific
  receptor subunits on different cell populations, e.g. T cells, innate lymphoid cells
  (ILC) or effector cells such as osteoblasts, fibroblasts or keratinocytes leads
  to activation of a specific JAK-STAT pathway. The different isoforms of JAK are
  coupled to specific receptor/cytokine pairs and allow for a targeted inhibition
  with a specific JAKinib. However, overlap exists allowing for unintended side effects
  or accumulative effects. JAK1-specific inhibitors for example affect signaling by
  IL-6, IL-21, IL-7, IL-9 and IL-22 targeting most of the relevant immune and effector
  cell populations in SpA pathogenesis.
pmcid: PMC7609840
papertitle: Impact of Janus Kinase Inhibition on the Treatment of Axial Spondyloarthropathies.
reftext: Ariane Hammitzsch, et al. Front Immunol. 2020;11:591176.
pmc_ranked_result_index: '55903'
pathway_score: 0.9248067
filename: fimmu-11-591176-g001.jpg
figtitle: Relevant JAK-STAT signaling pathways in the pathogenesis of Spondyloarthritis
year: '2020'
organisms: Homo sapiens
ndex: ''
annotations: []
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC7609840__fimmu-11-591176-g001.html
  '@type': Dataset
  description: Schematic representation of relevant JAK-STAT signaling pathways in
    the pathogenesis of Spondyloarthritis. Binding of the different Interleukins (IL)
    to their specific receptor subunits on different cell populations, e.g. T cells,
    innate lymphoid cells (ILC) or effector cells such as osteoblasts, fibroblasts
    or keratinocytes leads to activation of a specific JAK-STAT pathway. The different
    isoforms of JAK are coupled to specific receptor/cytokine pairs and allow for
    a targeted inhibition with a specific JAKinib. However, overlap exists allowing
    for unintended side effects or accumulative effects. JAK1-specific inhibitors
    for example affect signaling by IL-6, IL-21, IL-7, IL-9 and IL-22 targeting most
    of the relevant immune and effector cell populations in SpA pathogenesis.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - IL7
  - IL9
  - IL6
  - IL23A
  - IL21
  - IL22
  - IL6R
  - IL23R
  - IL12RB1
  - IL10RB
  - JAK2
  - TYK2
  - JAK1
  - JAK3
  - STAT1
  - STAT4
  - STAT3
  - STAT5A
  - STAT5B
  - CD48
genes:
- word: IL-7,
  symbol: IL-7
  source: hgnc_alias_symbol
  hgnc_symbol: IL7
  entrez: '3574'
- word: IL-9,
  symbol: IL-9
  source: hgnc_alias_symbol
  hgnc_symbol: IL9
  entrez: '3578'
- word: IL-6
  symbol: IL-6
  source: hgnc_alias_symbol
  hgnc_symbol: IL6
  entrez: '3569'
- word: IL-23
  symbol: IL-23
  source: hgnc_alias_symbol
  hgnc_symbol: IL23A
  entrez: '51561'
- word: IL-21
  symbol: IL21
  source: hgnc_symbol
  hgnc_symbol: IL21
  entrez: '59067'
- word: IL-22
  symbol: IL22
  source: hgnc_symbol
  hgnc_symbol: IL22
  entrez: '50616'
- word: IL-6R
  symbol: IL6R
  source: hgnc_symbol
  hgnc_symbol: IL6R
  entrez: '3570'
- word: IL-23R
  symbol: IL-23R
  source: hgnc_alias_symbol
  hgnc_symbol: IL23R
  entrez: '149233'
- word: IL-12RB1
  symbol: IL12RB1
  source: hgnc_symbol
  hgnc_symbol: IL12RB1
  entrez: '3594'
- word: IL-10RB
  symbol: IL10RB
  source: hgnc_symbol
  hgnc_symbol: IL10RB
  entrez: '3588'
- word: JAK2
  symbol: JAK2
  source: hgnc_symbol
  hgnc_symbol: JAK2
  entrez: '3717'
- word: TYK2
  symbol: TYK2
  source: hgnc_symbol
  hgnc_symbol: TYK2
  entrez: '7297'
- word: JAK2
  symbol: JAK2
  source: hgnc_symbol
  hgnc_symbol: JAK2
  entrez: '3717'
- word: TYK2
  symbol: TYK2
  source: hgnc_symbol
  hgnc_symbol: TYK2
  entrez: '7297'
- word: JAK1
  symbol: JAK1
  source: hgnc_symbol
  hgnc_symbol: JAK1
  entrez: '3716'
- word: JAK3
  symbol: JAK3
  source: hgnc_symbol
  hgnc_symbol: JAK3
  entrez: '3718'
- word: JAK1
  symbol: JAK1
  source: hgnc_symbol
  hgnc_symbol: JAK1
  entrez: '3716'
- word: TYK2
  symbol: TYK2
  source: hgnc_symbol
  hgnc_symbol: TYK2
  entrez: '7297'
- word: JAK1
  symbol: JAK1
  source: hgnc_symbol
  hgnc_symbol: JAK1
  entrez: '3716'
- word: STAT1
  symbol: STAT1
  source: hgnc_symbol
  hgnc_symbol: STAT1
  entrez: '6772'
- word: STAT1
  symbol: STAT1
  source: hgnc_symbol
  hgnc_symbol: STAT1
  entrez: '6772'
- word: STAT4
  symbol: STAT4
  source: hgnc_symbol
  hgnc_symbol: STAT4
  entrez: '6775'
- word: STAT3
  symbol: STAT3
  source: hgnc_symbol
  hgnc_symbol: STAT3
  entrez: '6774'
- word: STAT3
  symbol: STAT3
  source: hgnc_symbol
  hgnc_symbol: STAT3
  entrez: '6774'
- word: STAT3
  symbol: STAT3
  source: hgnc_symbol
  hgnc_symbol: STAT3
  entrez: '6774'
- word: STAT3
  symbol: STAT3
  source: hgnc_symbol
  hgnc_symbol: STAT3
  entrez: '6774'
- word: STAT5
  symbol: STAT5
  source: bioentities_symbol
  hgnc_symbol: STAT5A
  entrez: '6776'
- word: STAT5
  symbol: STAT5
  source: bioentities_symbol
  hgnc_symbol: STAT5B
  entrez: '6777'
- word: STAT5
  symbol: STAT5
  source: bioentities_symbol
  hgnc_symbol: STAT5A
  entrez: '6776'
- word: STAT5
  symbol: STAT5
  source: bioentities_symbol
  hgnc_symbol: STAT5B
  entrez: '6777'
- word: STAT1
  symbol: STAT1
  source: hgnc_symbol
  hgnc_symbol: STAT1
  entrez: '6772'
- word: STAT3
  symbol: STAT3
  source: hgnc_symbol
  hgnc_symbol: STAT3
  entrez: '6774'
- word: STAT3
  symbol: STAT3
  source: hgnc_symbol
  hgnc_symbol: STAT3
  entrez: '6774'
- word: blast
  symbol: BLAST
  source: hgnc_alias_symbol
  hgnc_symbol: CD48
  entrez: '962'
chemicals: []
diseases: []
figid_alias: PMC7609840__F1
redirect_from: /figures/PMC7609840__F1
figtype: Figure
---
